Timber Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 4.06 million compared to USD 3.07 million a year ago. Basic loss per share from continuing operations was USD 1.32 compared to USD 2.41 a year ago.
Trex Wind-down, Inc. OTC Markets
Equities
TMBR
US8870802084
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -50.00% | -50.00% | -91.67% |
1st Jan change | Capi. | |
---|---|---|
+40.50% | 54.04B | |
+45.55% | 41.96B | |
-1.30% | 41.92B | |
-7.20% | 28.35B | |
+12.49% | 26.35B | |
-21.12% | 19B | |
+6.66% | 13B | |
+29.02% | 12.28B | |
+25.95% | 12.19B |